αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?
Parkinson’s Disease (PD) is a complex, chronic, progressive, and debilitating neurodegenerative disorder. Neither a cure nor effective long-term therapy exist and the lack of knowledge of the molecular mechanisms responsible for PD development is a major impediment to therapeutic advances. The prote...
Saved in:
Main Authors: | David Protter, Charmaine Lang, Antony A. Cooper |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2012/829207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First?
by: Michela Zaltieri, et al.
Published: (2015-01-01) -
The Contribution of α-Synuclein Spreading to Parkinson’s Disease Synaptopathy
by: Francesca Longhena, et al.
Published: (2017-01-01) -
Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis
by: Simone A. van den Berge, et al.
Published: (2012-01-01) -
Mitochondrial Dysfunction in Parkinson's Disease
by: P. C. Keane, et al.
Published: (2011-01-01) -
Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain
by: Alexandra Dumitriu, et al.
Published: (2012-01-01)